Financhill
Back

Oncternal Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
35

ONCT
Oncternal Therapeutics

Last Price:
1.29
Seasonality Move:
21.38%
Sell
39

NBY
NovaBay Pharmaceuticals

Last Price:
0.70
Seasonality Move:
-7.72%
Sell
35
Oncternal Therapeutics (ONCT) is a Sell

Is Oncternal Therapeutics a Buy, Sell or Hold?

  • The current Oncternal Therapeutics [ONCT] share price is $1.27. The Score for ONCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ONCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.69. The Score for NBY is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ONCT Stock Price Chart

What is Oncternal Therapeutics's stock price today?

  • The Oncternal Therapeutics share price today is $1.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ONCT is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.69
    The current trend is relatively stagnant and NBY is experiencing slight buying pressure.

ONCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 39.87 Sell
Chaikin Money Flow: -99296 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.2 - 1.66) Sell
Bollinger Bands (100): (1.6 - 6.64) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 53.8 Buy
Chaikin Money Flow: 74506 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.72) Buy
Bollinger Bands (100): (0.3 - 1.7) Sell

ONCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.49 Sell
20-day SMA: 1.48 Sell
50-day SMA: 1.92 Sell
200-day SMA: 6.5 Sell
8-day EMA: 1.47 Sell
20-day EMA: 1.52 Sell
50-day EMA: 2.22 Sell
200-day EMA: 5.5 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.73 Sell
20-day SMA: 0.65 Buy
50-day SMA: 0.61 Buy
200-day SMA: 2.57 Sell
8-day EMA: 0.7 Sell
20-day EMA: 0.68 Buy
50-day EMA: 0.74 Sell
200-day EMA: 6.08 Sell

Oncternal Therapeutics Earnings Growth & ONCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.51 per share, and an increase next year of $1.64 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Oncternal Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):